Aspects of pneumococcal infection including bacterial virulence, host response and vaccination.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 2649678)

Published in J Med Microbiol on April 01, 1989

Authors

S H Gillespie1

Author Affiliations

1: London School of Hygiene and Tropical Medicine.

Articles citing this

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev (1995) 3.12

Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun (2005) 2.60

Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06

T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun (2000) 1.60

Should patients positive for HIV infection receive pneumococcal vaccine? BMJ (1995) 1.53

Hemin utilization is related to virulence of Streptococcus pneumoniae. Infect Immun (1993) 1.45

The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC Microbiol (2003) 1.15

Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev (2008) 1.07

Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Infect Immun (2001) 1.01

Streptococcus pneumoniae. Thorax (1999) 0.90

Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice. Infect Immun (1996) 0.85

Meningitis due to a multiply resistant pneumococcus. J R Soc Med (1992) 0.84

An outbreak of penicillin resistant Streptococcus pneumoniae investigated by a polymerase chain reaction based genotyping method. J Clin Pathol (1997) 0.84

Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae. Thorax (1994) 0.83

Interference with the oxidative response of neutrophils by Streptococcus pneumoniae. Thorax (1993) 0.82

Detection of C-polysaccharide in serum of patients with Streptococcus pneumoniae bacteraemia. J Clin Pathol (1995) 0.81

Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate. Infect Immun (1994) 0.80

In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin. Sci Rep (2015) 0.78

Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae. Infect Immun (2000) 0.78

Transcriptome analysis of Streptococcus pneumoniae treated with the designed antimicrobial peptides, DM3. Sci Rep (2016) 0.75

PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia. J Immunol (2016) 0.75